My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 104

2.

Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy.

Brown P.

Haemophilia. 2007 Dec;13 Suppl 5:33-40. Review.PMID: 18078395 [PubMed - indexed for MEDLINE]Related articles

3.

The impact of Creutzfeldt-Jakob disease on surgical practice.

Lumley JS; CJD Incidents Panel; Engineering and Scientific Advisory Committee-Pr; National Blood Transfusion Committee, Serious Hazards of Transfusion Committee.

Ann R Coll Surg Engl. 2008 Mar;90(2):91-4. Review.PMID: 18325202 [PubMed - indexed for MEDLINE]Related articlesFree article

4.

An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.

Turner ML, Ludlam CA.

Br J Haematol. 2009 Jan;144(1):14-23. Epub 2008 Oct 17. Review.PMID: 18950452 [PubMed - indexed for MEDLINE]Related articles

5.

[The risk of prion contamination through the transfusion of cellular products]

Lefrère JJ.

Transfus Clin Biol. 2007 May;14(1):25-34. Epub 2007 May 11. French. PMID: 17499536 [PubMed - indexed for MEDLINE]Related articles

7.

Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study.

Dorsey K, Zou S, Schonberger LB, Sullivan M, Kessler D, Notari E 4th, Fang CT, Dodd RY.

Transfusion. 2009 May;49(5):977-84. Epub 2009 Jan 5.PMID: 19170987 [PubMed - indexed for MEDLINE]Related articles

8.

Blood transfusion and spread of variant Creutzfeldt-Jakob disease.

Dietz K, Raddatz G, Wallis J, Müller N, Zerr I, Duerr HP, Lefèvre H, Seifried E, Löwer J.

Emerg Infect Dis. 2007 Jan;13(1):89-96.PMID: 17370520 [PubMed - indexed for MEDLINE]Related articlesFree article

9.

Application of Atomic Dielectric Resonance Spectroscopy for the screening of blood samples from patients with clinical variant and sporadic CJD.

Fagge TJ, Barclay GR, Stove GC, Stove G, Robinson MJ, Head MW, Ironside JW, Turner ML.

J Transl Med. 2007 Aug 30;5:41.PMID: 17760958 [PubMed - indexed for MEDLINE]Related articlesFree article

10.

From mad cows to sensible blood transfusion: the risk of prion transmission by labile blood components in the United Kingdom and in France.

Lefrère JJ, Hewitt P.

Transfusion. 2009 Apr;49(4):797-812. Epub 2009 Jan 2. Review.PMID: 19170997 [PubMed - indexed for MEDLINE]Related articles

11.

Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts--Japan, 1978-2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Oct 24;57(42):1152-4. Erratum in: MMWR Morb Mortal Wkly Rep. 2008 Oct 31;57(43):1181.. PMID: 18946463 [PubMed - indexed for MEDLINE]Related articlesFree article

12.

Creutzfeldt-Jakob disease: therapeutic strategies.

Beringue V, Deslys JP, Adjou KT, Dormont D.

Expert Opin Investig Drugs. 1997 Apr;6(4):345-8.PMID: 15989603 [PubMed]Related articles

13.

Prion safety of transfusion plasma and plasma-derivatives typically used for prophylactic treatment.

Svae TE, Neisser-Svae A, Bailey A, Reichl H, Biesert L, Schmidt T, Heger A, Römisch J.

Transfus Apher Sci. 2008 Aug;39(1):59-67. Epub 2008 Jul 10.PMID: 18619902 [PubMed - indexed for MEDLINE]Related articles

14.

Variant Creutzfeldt-Jakob disease and the Canadian blood system after the tainted blood tragedy.

Wilson K, Graham I, Ricketts M, Dornan C, Laupacis A, Hebert P.

Soc Sci Med. 2007 Jan;64(1):174-85. Epub 2006 Oct 2.PMID: 17014945 [PubMed - indexed for MEDLINE]Related articles

15.

[Transfusion risk analysis with regard to vCJD in France]

Martin M, Legras JF, Pouchol E, Trouvin JH.

Transfus Clin Biol. 2006 Nov;13(5):298-303. Epub 2006 Dec 22. French. PMID: 17188540 [PubMed - indexed for MEDLINE]Related articles

16.

Persistent propagation of variant Creutzfeldt-Jakob disease agent in murine spleen stromal cell culture with features of mesenchymal stem cells.

Akimov S, Yakovleva O, Vasilyeva I, McKenzie C, Cervenakova L.

J Virol. 2008 Nov;82(21):10959-62. Epub 2008 Aug 20.PMID: 18715934 [PubMed - indexed for MEDLINE]Related articlesFree article

17.

The impact of social amplification and attenuation of risk and the public reaction to mad cow disease in Canada.

Lewis RE, Tyshenko MG.

Risk Anal. 2009 May;29(5):714-28. Epub 2009 Jan 14.PMID: 19192234 [PubMed - indexed for MEDLINE]Related articles

18.

Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.

Mead S, Poulter M, Uphill J, Beck J, Whitfield J, Webb TE, Campbell T, Adamson G, Deriziotis P, Tabrizi SJ, Hummerich H, Verzilli C, Alpers MP, Whittaker JC, Collinge J.

Lancet Neurol. 2009 Jan;8(1):57-66.PMID: 19081515 [PubMed - indexed for MEDLINE]Related articlesFree article

19.

[Epidemiological surveillance of Creutzfeldt-Jakob in France]

Brandel JP, Salomon D, Capek I, Vaillant V, Alpérovitch A.

Rev Neurol (Paris). 2009 Aug-Sep;165(8-9):684-93. Epub 2009 May 20. Review. French. PMID: 19467685 [PubMed - indexed for MEDLINE]Related articles

20.

Risk of Creutzfeldt-Jakob disease transmission by ocular surgery and tissue transplantation.

Armitage WJ, Tullo AB, Ironside JW.

Eye (Lond). 2009 Oct;23(10):1926-30. Epub 2009 Jan 9.PMID: 19136921 [PubMed - in process]Related articles

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Write to the Help Desk